Registry for managing Helicobacter pylori infection in Argentina
Argentinean Registry on the Management of Helicobacter Pylori Infection
This study collects information from doctors in Argentina to see how well different treatments work for Helicobacter pylori infections and to find the best ways to use antibiotics responsibly.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Buenos Aires Academic / other |
| Locations | 1 site (Ciudad de Buenos Aires) |
| Trial ID | NCT06579365 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect data on the management of Helicobacter pylori infections among Argentinean gastroenterologists. It focuses on understanding the effectiveness of various treatment regimens and the local antibiotic resistance profiles. By systematically documenting routine clinical practices, the registry seeks to identify optimal therapies that can be used empirically to improve eradication rates. The study will also explore the principles of antimicrobial stewardship to minimize inappropriate antibiotic use.
Who should consider this trial
Good fit: Ideal candidates for this registry are adult patients diagnosed with Helicobacter pylori infection.
Not a fit: Patients who are pregnant, lactating, or currently taking antibiotics may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies for Helicobacter pylori infections, enhancing patient outcomes and reducing antibiotic resistance.
How similar studies have performed: While similar registries have been conducted, this specific approach focusing on Argentinean practices and antibiotic resistance profiles is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Infected adult patients by Helicobacter pylori \- Exclusion Criteria: Pregnant or lactating women Subjects currently taking any antibiotics Administration of antibiotics or bismuth in the preceding 4 weeks or PPI 2 weeks previous Unable or refuse to give consent
Where this trial is running
Ciudad de Buenos Aires
- Instituto de Investigaciones Medicas Alfredo Lanari. Universidad de Buenos Aires — Ciudad de Buenos Aires, Argentina (Recruiting)
Study contacts
- Study coordinator: Oscar M Laudanno, MD
- Email: oscarlaudanno@gmail.com
- Phone: 5491141693149
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.